MYCOF

Noveris Health Sciences Inc.

USD

Set alert

Price alert · MYCOF

All alert types
0.73 USD 0.00 0.00%
As of Oct 30, 2026
0.80 Day range 0.80
0.096 52-week range 2.00
YTD
+234.86%
1 year
+209.32%
Open
0.80
Prev close
0.73
Mkt cap
42.74M
Vol
1.00K
Avg vol
153
EPS
1.89
P/E
0.39
More statistics
Low
0.80
High
0.80

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for MYCOF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-206.05 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 4
  • P/B 1

Valuation

P/E 0.1×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.1×FY 2020: -0.0×FY 2021: -0.0×FY 2022: -0.4×FY 2023: -0.0×FY 2024: -0.1×FY 2025: 0.1×
FY 2016 5y median -0.0× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.2×FY 2019: 1.6×FY 2020: 380×FY 2021: 86.9×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.3×FY 2021: 3.1×FY 2022: -1.4×FY 2023: -0.1×FY 2024: -0.0×FY 2025: -0.0×
FY 2016 5y median -0.0× FY 2025
P/FCF 39.4×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.1×FY 2020: -0.1×FY 2021: -0.0×FY 2022: -0.6×FY 2023: -0.1×FY 2024: -6.4×FY 2025: 39.4×
FY 2016 5y median -0.1× FY 2025
EV/EBITDA 3.2×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: -0.3×FY 2019: -0.0×FY 2020: -0.2×FY 2021: -0.2×FY 2022: -0.6×FY 2023: -0.6×FY 2024: -2.9×FY 2025: 3.2×
FY 2016 5y median -0.6× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 8.6×FY 2019: 1.9×FY 2020: 764×FY 2021: 488×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield 2.5%
FY 2016: -15323.4%FY 2017: -22195.9%FY 2018: -7799.8%FY 2019: -775.2%FY 2020: -768.7%FY 2021: -3756.9%FY 2022: -168.1%FY 2023: -696.4%FY 2024: -15.5%FY 2025: 2.5%
FY 2016 5y median -168.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 47.1%FY 2019: 25.1%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -2792.7%FY 2019: -2642.2%FY 2020: -428262.5%FY 2021: -294931.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -6431.4%FY 2019: -2968.2%FY 2020: -1029764.8%FY 2021: -385658.6%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -23.4%
FY 2016: -573.9%FY 2017: -1400.3%FY 2018: -397.1%FY 2019: -37.1%FY 2020: -756.8%FY 2021: -13674.8%FY 2022: 329.1%FY 2023: 175.8%FY 2024: 21.1%FY 2025: -23.4%
FY 2016 5y median 21.1% FY 2025
ROIC 19.6%
FY 2016: 274.8%FY 2017: -1178.0%FY 2018: -113.6%FY 2019: -32.9%FY 2020: -165.9%FY 2021: -462.7%FY 2022: -293.9%FY 2023: 144.7%FY 2024: 30.9%FY 2025: 19.6%
FY 2016 5y median 19.6% FY 2025
ROA 30118.1%
FY 2016: -287.5%FY 2017: -630.3%FY 2018: -256.4%FY 2019: -36.3%FY 2020: -282.7%FY 2021: -381.2%FY 2022: -171.7%FY 2023: -9863.0%FY 2024: -6229.8%FY 2025: 30118.1%
FY 2016 5y median -381.2% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -100.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -39.5%FY 2020: -97.9%FY 2021: 186.3%FY 2022: -100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 77.9%
FY 2016: 12.6%FY 2017: -474.8%FY 2018: 63.1%FY 2019: 42.8%FY 2020: -237.8%FY 2021: -97.2%FY 2022: 28.9%FY 2023: 40.2%FY 2024: 73.5%FY 2025: 77.9%
FY 2016 FY 2025
EPS (diluted) 4580.2%
FY 2016: -27.3%FY 2017: -27.9%FY 2018: 60.8%FY 2019: 93.1%FY 2020: -41.2%FY 2021: 47.8%FY 2022: 77.8%FY 2023: 50.4%FY 2024: 92.2%FY 2025: 4580.2%
FY 2016 FY 2025
Free Cash Flow 125.1%
FY 2016: -49.7%FY 2017: -144.7%FY 2018: 26.0%FY 2019: 61.5%FY 2020: -397.7%FY 2021: -219.7%FY 2022: 65.4%FY 2023: 50.2%FY 2024: 99.1%FY 2025: 125.1%
FY 2016 FY 2025

Financial Health

Current Ratio 0.0×
FY 2016: 0.5×FY 2017: 1.8×FY 2018: 0.3×FY 2019: 2.9×FY 2020: 0.4×FY 2021: 1.8×FY 2022: 1.5×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Quick Ratio 0.0×
FY 2016: 0.5×FY 2017: 2.0×FY 2018: 0.3×FY 2019: 0.5×FY 2020: 0.4×FY 2021: 1.8×FY 2022: 1.5×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Debt / Equity -0.8×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.5×FY 2019: 0.0×FY 2020: 0.9×FY 2021: 21.3×FY 2022: -1.3×FY 2023: -0.5×FY 2024: -0.5×FY 2025: -0.8×
FY 2016 5y median -0.5× FY 2025
Net Debt / EBITDA 3.0×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: -0.3×FY 2019: -0.0×FY 2020: -0.1×FY 2021: -0.1×FY 2022: -0.3×FY 2023: -0.6×FY 2024: -2.8×FY 2025: 3.0×
FY 2016 5y median -0.3× FY 2025
Interest Coverage -2.5×
FY 2016: 88.3×FY 2017: -2277×FY 2018: -82.9×FY 2019: -48.6×FY 2020: -61.3×FY 2021: -108×FY 2022: -17.2×FY 2023: -7.2×FY 2024: -1.7×FY 2025: -2.5×
FY 2016 5y median -7.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31